Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalNot applicablepeer-review

2 Scopus Citations
View graph of relations

Author(s)

  • Qing Pan
  • Carmen O. K. Law
  • Mingo M. H. Yung
  • K. C. Han
  • Yuen Lam Pon

Related Research Unit(s)

Detail(s)

Original languageEnglish
Article numbere0198980
Journal / PublicationPLoS ONE
Volume13
Issue number10
Online published10 Oct 2018
Publication statusPublished - 10 Oct 2018

Link(s)

Abstract

Gastric cancer is the third most common cause of death from cancer in the world and it remains difficult to cure in Western countries, primarily because most patients present with advanced disease. Currently, CEA, CA50 and CA72-4 are commonly used as tumor markers for gastric cancer by immunoassays. However, the drawback and conundrum of immunoassay are the unceasing problem in standardization of quality of antibodies and time/ effort for the intensive production. Therefore, there is an urgent need for the development of a standardized assay to detect gastric cancer at the early stage. Aptamers are DNA or RNA oligonucleotides with structural domain which recognize ligands such as proteins with superior affinity and specificity when compared to antibodies. In this study, SELEX (Systematic Evolution of Ligands by Exponential enrichment) technique was adopted to screen a random 30mer RNA library for aptamers targeting CEA, CA50 and CA72-4 respectively. Combined with high-throughput sequencing, we identified 6 aptamers which specifically target for these three biomarkers of gastrointestinal cancer. Intriguingly, the predicted secondary structures of RNA aptamers from each antigen showed significant structural similarity, suggesting the structural recognition between the aptamers and the antigens. Moreover, we determined the dissociation constants of all the aptamers to their corresponding antigens by fluorescence spectroscopy, which further demonstrated high affinities between the aptamers and the antigens. In addition, immunostaining of gastric adenocarcinoma cell line AGS using CEA Aptamer probe showed positive fluorescent signal which proves the potential of the aptamer as a detection tool for gastric cancer. Furthermore, substantially decreased cell viability and growth were observed when human colorectal cell line LS-174T was transfected with each individual aptamers. Taking together, these novel RNA aptamers targeting gastrointestinal cancer biomarker CEA, CA50 and CA72-4 will aid further development and standardization of clinical diagnostic method with better sensitivity and specificity, and potentially future therapeutics development of gastric cancer.

Research Area(s)

  • INTEGRATED MICROFLUIDIC SYSTEM, NUCLEIC-ACID APTAMERS, CARCINOEMBRYONIC ANTIGEN, DNA APTAMERS, QUANTITATIVE SELECTION, CELL-SELEX, EVOLUTION, THERAPY, LIGANDS, DISEASE

Citation Format(s)

Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity. / Pan, Qing; Law, Carmen O. K.; Yung, Mingo M. H.; Han, K. C.; Pon, Yuen Lam; Lau, Terrence Chi Kong.

In: PLoS ONE, Vol. 13, No. 10, e0198980, 10.10.2018.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalNot applicablepeer-review

Download Statistics

No data available